Tag Archives: healthcare

2017/03/28 Commentary: Hopes and Dopes

2017/03/28 Commentary: Hopes and Dopes © 2017 ROHR International, Inc. All International rights reserved. Extended Trend Assessments reserved for Gold and Platinum Subscribers Commentary: Tuesday, March 28, 2017 Hopes and Dopes   The old adage “hope springs eternal” seems to Read more…

Rohr Market Research Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

2017/03/24 Commentary: Healthcare Reform Rx

2017/03/24 Commentary: Healthcare Reform Rx © 2017 ROHR International, Inc. All International rights reserved. Extended Trend Assessments reserved for Gold and Platinum Subscribers Commentary: Friday, March 24, 2017 Healthcare Reform Rx The question seems to be whether there is indeed Read more…

Rohr Market Research Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

2017/03/22 Commentary: ‘Vol’ is Back & ‘Regular Order’

2017/03/22 Commentary: ‘Vol’ is Back & ‘Regular Order’ © 2017 ROHR International, Inc. All International rights reserved. Extended Trend Assessments reserved for Gold and Platinum Subscribers Commentary: Wednesday, March 22, 2017 ‘Vol’ is Back & ‘Regular Order’ Of course ‘Vol’ Read more…

Rohr Market Research Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

2017/03/16 Quick Take: ‘Fecstasy’ Wins… For Now

2017/03/16 Quick Take: ‘Fecstasy’ Wins… For Now © 2017 ROHR International, Inc. All International rights reserved. Extended Trend Assessments reserved for Gold and Platinum Subscribers Quick Take: Thursday, March 16, 2017 ‘Fecstasy’ Wins… For Now As explored in Wednesday morning’s Read more…

Rohr Market Research Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

2017/03/15 Quick Take: ‘Fecstasy’ or ‘Fedache’?

2017/03/15 Quick Take: ‘Fecstasy’ or ‘Fedache’? © 2017 ROHR International, Inc. All International rights reserved. Extended Trend Assessments reserved for Gold and Platinum Subscribers Quick Take: Wednesday, March 15, 2017 ‘Fecstasy’ or ‘Fedache’? So what will it be? Janet Yellen Read more…

Rohr Market Research Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,